We are live on
!
Find out more
NRC
North Run Capital Portfolio holdings
AUM
$43.5M
1-Year Est. Return
38.24%
This Fund
S&P 500
This Quarter
Est. Return
+4.85%
1 Year Est. Return
-38.24%
3 Year Est. Return
+19.43%
5 Year Est. Return
+17.57%
10 Year Est. Return
–
AUM
$1.03B
AUM Growth
+$44.2M
(+4.5%)
Cap. Flow
-$5.04M
Cap. Flow
% of AUM
-0.49%
Top 10 Holdings %
Top 10 Hldgs %
64.97%
Holding
33
New
3
Increased
10
Reduced
8
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
INXN
Interxion Holding N.V.
INXN
|
+$37.6M |
| 2 |
TIBX
TIBCO SOFTWARE INC
TIBX
|
+$29.6M |
| 3 |
GIMO
Gigamon Inc.
GIMO
|
+$22M |
| 4 |
XXIA
Ixia
XXIA
|
+$18.6M |
| 5 |
NRF
NorthStar Realty Finance Corp.
NRF
|
+$11.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$32.6M |
| 2 |
SIR
SELECT INCOME REIT
SIR
|
+$30.3M |
| 3 |
ATI
ATI
|
+$19.4M |
| 4 |
Teva Pharmaceuticals
TEVA
|
+$16.1M |
| 5 |
HSP
HOSPIRA INC
HSP
|
+$14.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.17% |
| 2 | Consumer Discretionary | 20.46% |
| 3 | Financials | 10.44% |
| 4 | Communication Services | 8.74% |
| 5 | Industrials | 7.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Boston Scientific
BSX
$69.5B
| $3.17M | 0.31% |
248,000
-2,507,000
| -91% | -$32.6M |
|
|
INXN
27
CALL
DELISTED
Interxion Holding N.V.
INXN
| $2.88M | 0.28% |
+105,000
| New | +$2.73M |
|
|
DLIA
28
DELISTED
DELIA*S INC
DLIA
| $2.03M | 0.2% |
2,670,096
-68,000
| -2% | -$51.9K |
|
29
PUT
Liquidity Services
LQDT
$1.22B
| – | – |
-209,600
| Closed | -$5.46M |
|
30
Telephone and Data Systems
TDS
$3.82B
| – | – |
-432,967
| Closed | -$11.3M |
|
|
QVCGA
31
DELISTED
QVC Group Inc Series A
QVCGA
| – | – |
-11,426
| Closed | -$13.5M |
|
|
GTS
32
DELISTED
Triple-S Management Corporation
GTS
| – | – |
-629,591
| Closed | -$9.67M |
|
|
SIR
33
DELISTED
SELECT INCOME REIT
SIR
| – | – |
-2,275,000
| Closed | -$30.3M |
|
Similar funds
ACM
HA
JI
CCS
BGP
EOCM
SJIA
LN
North Run Capital's Q2 2014 Portfolio in Review
As of Q2 2014, North Run Capital held 33 positions worth $1.03B, up 4.5% from $984M the previous quarter. Its ten largest holdings account for 65% of the portfolio.
North Run Capital's Q2 2014 filing shows 3 new, 10 increased, 8 reduced and 5 closed positions. Its largest new stake was Gigamon Inc.: 1,216,800 shares worth $23.3M. The largest sale was Boston Scientific, an estimated $32.6M.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 32% a quarter earlier, followed by Consumer Discretionary and Financials.
- North Run Capital's largest Q2 2014 buy was Gigamon Inc.: 1,216,800 shares worth $23.3M.
- North Run Capital added most to Interxion Holding N.V. in Q2 2014, an estimated $37.6M increase.
- North Run Capital's biggest Q2 2014 reduction was Boston Scientific, cutting an estimated $32.6M.
- North Run Capital fully exited SELECT INCOME REIT in Q2 2014, selling an estimated $30.3M.
- North Run Capital's ten largest holdings make up 65% of its $1.03B portfolio in Q2 2014.
- North Run Capital opened 3 new positions and closed 5 in Q2 2014.
- North Run Capital's portfolio value rose 4.5% quarter-over-quarter to $1.03B.
Based on North Run Capital's 13F filing for Q2 2014, filed 14 Aug 2014.